CNOT3 and lung carcinoma: We propose that the dysregulated c-Jun/CNOT3 axis can contribute to EGFR-TKIs resistance and CNOT3 is a potential target to enhance the chemosensitivity of lung cancer cells to EGFR-TKIs and to prevent metastatic progression (Fig. 6H).